Blanket Purchase Agreement W81XWH20A9065

Award Date 8/26/20
Last Date to Order 8/25/25
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency (DHA) awarded a $5.3 million single-award Blanket Purchase Agreement (BPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer of specialized genomic and proteomic research tools and services. The BPA, which runs through September 2027, enables DHA to issue firm-fixed-price delivery orders for custom DNA reagents, MYBAITS reagents, and other proprietary genomic products to support the agency's biomedical research...
The Defense Health Agency awarded Promega Corporation an indefinite delivery vehicle in the form of a blanket purchase agreement valued at up to $11.5 million. The BPA enables the agency to place fixed price calls for DNA analysis equipment, reagents, and related products to support its biomedical research and healthcare programs. Between September 2020 and the present date, the agency has exercised this BPA to award Promega eight calls valued between $816 and $261,323.68 each. The calls require...
This Blanket Purchase Agreement (BPA) contract, awarded by the Defense Health Agency (DHA) to Life Technologies Corporation, provides the agency with a range of scientific instruments, reagents, and consumables to support its healthcare and medical readiness missions. As a prime contractor, Life Technologies leverages its expertise as a manufacturer of specialized biotechnology products, including genetic analyzers, real-time PCR systems, flow cytometry instruments, and sample preparation...
The Blanket Purchase Agreement (BPA) identified by contract number HT001416A0087 was awarded by the Defense Health Agency (DHA), a defense agency, to Bio Rad Laboratories Inc., a large for-profit manufacturer of life science and clinical diagnostic products. The $6,500,000 single-award BPA, which does not have a small business set-aside, provides a streamlined procurement vehicle for the DHA to acquire a variety of specialized laboratory equipment, reagents, consumables, and maintenance services...
The Blanket Purchase Agreement (BPA) with Contract ID HT942523A0010 was awarded by the Defense Health Agency, a defense agency, to Government Scientific Source Inc., a for-profit organization. The BPA has a ceiling value of $15,168,264.18 and a period of performance through September 21, 2028. The BPA is for the procurement of general laboratory supplies and equipment to support the research and testing programs of various government agencies. Two BPA Calls have been issued to date, valued at...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency, a defense agency, to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The $2,000,000 single-award BPA has a period of performance through October 3, 2029 and is for the procurement of testing supplies for transfusion services. Werfen, as the prime contractor, will provide specialized medical devices, consumables, and support services to the Defense Health Agency, Department...
The Defense Health Agency (DHA) has awarded a $7.5 million Blanket Purchase Agreement (BPA) to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and diagnostic kits. The BPA serves as a master ordering vehicle for laboratory supplies to support federal healthcare and research initiatives across multiple agencies, including the Department of Health and Human Services (HHS) National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of Defense...
This Blanket Purchase Agreement (BPA) contract was awarded by the Defense Health Agency (DHA) to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The $249,000 single-award BPA has an ultimate completion date of August 31, 2028 and is for the delivery of ROTEM-brand consumable laboratory products to support the agency's healthcare programs. Under this IDV, DHA has issued multiple firm fixed-price BPA calls to Werfen USA, a highly experienced...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide COVID-19 testing equipment, supplies, and associated services to support the agency's pandemic response efforts. The initial BPA call was awarded on August 29, 2020 for COVID-19 testing stations and kits, with a potential value of $0 and a completion date of August 28, 2021. A subsequent BPA call for nucleic acid testing of...
This Blanket Purchase Agreement (BPA) contract, awarded by the U.S. Defense Health Agency, enables the agency to efficiently procure specialized in vitro diagnostic equipment, reagents, and consumables from Werfen USA LLC, a manufacturer of medical laboratory testing technologies. The contract, valued at up to $250,000 over its five-year term, allows the agency to issue task orders for a variety of medical testing capabilities, including coagulation analysis, blood banking, hematology,...
  • W81XWH20A9065
    Blanket Purchase Agreement
  • 8
    Federal Contract Awards

Edge Biosystems Inc. was awarded a blanket purchase agreement (BPA) by the Defense Health Agency to provide laboratory supplies. Under this BPA, five firm fixed price call contracts were issued between 2020 and 2023 totaling approximately $350,000.

The BPA calls procured various Performa brand 96-well plates for use in DNA analysis from Edge Biosystems Inc.'s facilities in San Jose, California. Plates delivered under the orders included the Performa DTR Ultra, Performa DTS Ultra, and Performa Ultra models. Places of performance were all listed as San Jose, California. The Defense Health Agency aims to support the U.S. military health system and its nearly 10 million beneficiaries through programs such as medical research and development. Laboratory equipment and supplies of the type contracted would aid these efforts.

No set-aside provisions or subcontracting arrangements were specified in the BPA or associated calls. Edge Biosystems Inc. served as prime contractor, with periods of performance ranging from approximately one month to one year depending on the individual order. Collectively these orders further the Defense Health Agency's mission by providing DNA analysis materials for use in its medical research and development programs.

Generated 1/4/24, 6:46 PM